Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
NIH HIV Vaccine Candidate Shown Ineffective
AIDS Research Alliance (ARA) today announced that it has discontinued administering the HIV Vaccine Trials Network (HVTN) 505 HIV vaccine candidate, as preliminary data indicate that the vaccine strategy is ineffective. “Despite these disappointing results, no viral infection has ever been... - April 26, 2013 - AIDS Research Alliance
ALPCO Launches Their First STELLUX Chemiluminescent ELISA
ALPCO announces the launch of their STELLUX Rodent Insulin ELISA, the first ELISA launched in their new STELLUX Chemiluminescent assay product line. - April 26, 2013 - ALPCO
New Efficient Reagents for mRNA Transfection in Classic and Stem Cells
OZ Biosciences SAS, specialized in the development of innovative transfection technologies is delighted to announce the launching of new mRNA transfection Reagents : RmesFect™ and RmesFect™ Stem. - April 25, 2013 - OZ Biosciences
Light Drinking During Pregnancy: CanFASD Responds to Confusing Information That Continues to Cloud the Issue
“It is well known that Fetal Alcohol Spectrum Disorder (FASD) is the most common type of developmental disability worldwide, some of the most important unanswered questions in the field are 'how much alcohol in pregnancy is too much?' or what is a 'safe' amount of alcohol consumption in pregnancy and can we remember information on how much we drink accurately,” says Dr. Jocelynn Cook, Executive Director of the Canada Fetal Alcohol Spectrum Disorder Research Network (CanFASD). - April 24, 2013 - Canada FASD Research Network
A "Can’t Miss" Event in Houston Medical Center: Local Business, Amazing Spaces, Plans Big Bash to Celebrate 15th Anniversary and to Raise Money for Children's Hospital
Amazing Spaces Storage Centers hosting 15th Year Anniversary Event and Charity Event on May 16th, 2013 at 2412 W. Holcombe Blvd. in the Houston Medical Center. Guests will enjoy wine, made-to-order savory crepes, a photobooth, and raffle prizes. The event promises to be fun and unique, the highlight being a "Storage Wars" themed live auction benefiting the Shriners Hospitals for Children in Houston with celebrity auctioneer Walt Cade from the A&E hit show Storage Wars Texas. - April 19, 2013 - Amazing Spaces Storage Centers
Eminent Spine Texas Diamondback Minimally Invasive Screw System
Eminent Spine announces the first use of their Minimally Invasive Screw System. - April 19, 2013 - Eminent Spine
Diagnostic Rheumatology and Research, P.C. Chooses SpectraMedi, U.S. Based Transcription Service
Diagnostic Rheumatology and Research, P.C. has selected SpectraMedi to provide U.S. based medical transcription services. - April 13, 2013 - SpectraMedi MSO Medical Transcription Services & Technology Solutions
Protein Folding Research for Parkinson’s Disease Receives Research Funds
Protein folding research is at the forefront of some exciting discoveries for Parkinson's disease. Dr. Mark Fisher has been awarded $50,000 to further his protein folding research from the University of Kansas' Proof of Concept Fund. - April 10, 2013 - The University of Kansas Center for Technology Commercialization
Upcoming Drug Safety Training Opportunities
Don’t Miss Two New Interactive Drug Safety Training Sessions by Dr. Michael J. Klepper, Global Pharmacovigilance Expert, Coming This Spring - April 09, 2013 - Drug Safety Navigator, LLC
International Dementia Conference 2013, Phoeonix
The International Dementia Conference 2013 is coming to Phoenix, Arizon. This event is both sponsored and hosted by Dementia Therapy Specialists US and Dementia Doctor UK. The all inclusive conference is aimed at everyone working on the front line of dementia care, including ED's, Administrators, doctors and nurses of all disciplines, Home Managers, Care Workers, Social Workers, Researchers, educators and of course people living with dementia. - April 03, 2013 - Dementia Therapy Specialists
Meet the family with a DNA Ancestry Test: TestDiagnostics
Test diagnostics announces addition of new product in its store DNA Ancestry Test. - March 30, 2013 - Test Diagnostics
Smallpox Vaccine Clinical Study Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting Healthy M/F Age 18-40
A randomized, double-blind, placebo-controlled Phase III Trial to evaluate immunogenicity and safety of three consecutive production lots of the IMVAMUNE® smallpox vaccine in healthy subjects. - March 29, 2013 - Avail Clinical Research
KJT Group Continues to Grow
KJT Group, Inc. is pleased to welcome six new hires to its expanding healthcare research and consulting firm. The newest members of the research team are Carol Malach, Kevin Zheng and Jaclyn Guthart. Carol joins KJT Group as Research Manager and brings significant market research experience in... - March 29, 2013 - KJT Group
ICRC-Weyer Joins CDISC®, Expands Data Management
ICRC-Weyer GmbH, a German clinical contract research organization (CRO), has expanded its data management team and recently joined the Clinical Data Interchange Standards Consortium (CDISC®) on a gold-level membership. - March 28, 2013 - ICRC-Weyer GmbH
Amazing Spaces® Storage Centers Hosts 15th Year Anniversary Event to Thank Customers and to Fundraise for the Shriners Hospitals for Children
Amazing Spaces Storage Centers, a leading provider of upscale moving and storage solutions, announces their 15th Year Anniversary Event to be held on May 16th, 2013 at 2412 W. Holcombe Blvd. in the Houston Medical Center. The event promises to be fun and unique, the highlight being a "Storage Wars" themed live auction benefiting the Shriners Hospitals for Children in Houston. - March 26, 2013 - Amazing Spaces Storage Centers
New Plush Toy Cures the Smelly Gym Bag, Proceeds Benefit Duchenne Muscular Dystrophy Charity
Family invents odor-eliminating toy to “Get the ShtankOut,” while funding research for deadly disease. - March 26, 2013 - Shtankout
Growing Technology Commercialization: University of Kansas Moving Innovation from the Laboratory to the Marketplace
The University of Kansas is moving innovations from the laboratory to the marketplace at breakneck speed. Julie Goonewardene, President of KU Technology Commercialization Center, announced five researchers were awarded $50,000 each to further their research, research includes 1) medical delivery methods; 2) protein-based drugs for Parkinson's Disease; 3) new drugs for multiple sclerosis; 4) slide and tissue block valet system; 5) and solar panel detectors and sensors. - March 26, 2013 - The University of Kansas Center for Technology Commercialization
ALPCO Expands Product Offering with Addition of Flow Cytometry Reagents
After over twenty years of providing immunoassay kits worldwide, ALPCO has added flow cyometry reagents to their product offering. - March 25, 2013 - ALPCO
Arbovax Completes Successful Pre-Clinical Trial of Tetravalent Dengue Vaccine
Successful Pre-Clinical Tests Support Vaccine Platform, New Injection Protocol - March 19, 2013 - Arbovax Inc
Increasing Globalization Trends Driving the Market for Clinical Trial Cold Chain Services
A new report expects the total cold chain logistics spending on clinical trial materials to grow at a CAGR of around 4% during 2012-2016. - March 17, 2013 - IMARC Group
Dr. R. Wade McKenna to Speak on Stem Cell Therapy at T-POC & Newclip Technics 2013 Event
Dr. R. Wade McKenna, will share his expertise in stem cell therapy during the 2013 Dinner Event for The Progressive Orthopedic Company (T-POC) and Newclip Technics USA. The event will be held Friday, March 22 in Chicago, Illinois during the American Academy of Orthopaedic Surgeons 2013 Annual Meeting. - March 14, 2013 - Biologic Therapies
Polaris Study Offers Evidence of How Outcomes Management Technology Can Transform Child Welfare Services
Polaris shares the results of a multi-year study on the use of outcomes management technology in child welfare, and advocates for its widespread implementation. - March 14, 2013 - Polaris Health Directions
Healthcare Contract Research Outsourcing Market Research Report by Transparency Market Research
Transparency Market Research Add New “Healthcare Contract Research Outsourcing Market (Contract Research Organizations, Clinical Data Management, Clinical Trial Laboratories, Regulatory Medical Writing, Academic Medical Center) - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018” Market Research Report to It’s Database. - March 10, 2013 - Transparency Market Research
GenWay Biotech Names Dr. Ruben Flores-Saaib Vice President of Custom and Catalog Services
GenWay Biotech announces Ruben Flores-Saaib, PhD as Vice President of Custom and Catalog Services assuming responsibilities for the Company's custom services and catalog business operating activities. - March 06, 2013 - GenWay Biotech
Cliantha Research Partners with Acceliant for Its Clinical Trials
Acceliant, a global technology provider of innovative clinical trial data management solutions, today announced that Cliantha Research, a leading global Contract Research Organization, has chosen Acceliant's eClinical Suite for their clinical trial data management needs. Acceliant's integrated... - March 01, 2013 - Trianz
ICRC-Weyer Take Leading Role in Pharmacovigilance Writing for Drug Safety Reporting
The German clinical contract research organization (CRO), ICRC-Weyer GmbH, is extending their Medical Writing Services with specialized Pharmacovigilance Writing, a comprehensive solution for regulatory-compliant drug safety reporting. - March 01, 2013 - ICRC-Weyer GmbH
We-Care.com and AIDS Research Alliance Partner for HIV Research
AIDS Research Alliance (ARA) is pleased to announce that with We-Care.com’s generous support, it will be able to conduct the eight leukapheresis experiments necessary for the advancement of its promising HIV cure research. ARA was featured as We-Care.com’s Cause of the Month in December... - February 28, 2013 - AIDS Research Alliance
GHMI Partners with AnalizaDx to Bring Advanced Cancer Diagnostics to Africa
Simple blood-based cancer diagnostics and screening tests to enable early and effective treatment while reducing unnecessary procedures - February 27, 2013 - GHMI
Sengenics to Launch Global Biomarker Discovery and Clinical Trials Service Based on Oxford Gene Technology’s Patented Functional Protein Array
Sengenics today announced that it has signed an agreement with Oxford Gene Technology (OGT) to enable the launch of a global cancer biomarker discovery and clinical trial immuno-response monitoring service. The service will be based upon OGT’s proprietary full-length functional protein array... - February 25, 2013 - Sengenics
New Research Report on Cellular Therapy and Cord Blood 2013 Market Report by IndustryMonitor.co
IndustryMonitor.co Published Cellular Therapy and Cord Blood 2013 Market Report - February 25, 2013 - Industry Monitor
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2013 Market Report by IndustryMonitor.co
IndustryMonitor.co Published Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2013 Market Report. - February 25, 2013 - Industry Monitor
New Research Report MicroRNAs and Exosomes Market Report 2012 by IndustryMonitor.co
IndustryMonitor.co Published MicroRNAs and Exosomes Market Report 2012. - February 25, 2013 - Industry Monitor
New Osteoporosis Statistics Released by TestDiagnostics
TestDiagnostics market survey, found that the number of women and men being diagnosed with osteoporosis are rising at an alarming level. - February 16, 2013 - Test Diagnostics
IonSense to Present Direct Analysis in Real Time (DART®) Analysis for Rapid Drug Screening at the American Academy of Forensic Sciences (AAFS) 65th Annual Meeting
IonSense will present its DART-MS technology for rapid screening of urine samples using solid phase microfiber probes, enabling sample inspection for drugs of abuse in minutes. This is the first time IonSense will exhibit at the AAFS meeting, February 18-23, 2013 in Washington, D.C., Booth 405. - February 14, 2013 - IonSense, Inc.
iMPak Health Announces Agreement to License HealthSaaS Connected Outcomes Platform
iMPak Health, a subsidiary of Meridian Health, today announced a white labeling agreement with HealthSaaS for their Connected Outcomes Platform. This agreement will enhance iMPak’s device offerings by bringing patient data into the clinical workflow as an asset while reducing manual data entry and providing actionable information to healthcare providers. - February 13, 2013 - HealthSaaS, Inc
MarketResearchReports.biz Publishes Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
New Market Research Report Added in MarketResearchReports.Biz Database Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013 - February 13, 2013 - Market Research Reports.biz
Fruit Tree Nursery Offers Donations for Research During Congenital Heart Defect Awareness Week
Fruit tree nursery announces donation of gross sales to congenital heart defect research during Congenital Heart Defect Awareness Week, Feb. 7-14, 2012. - February 07, 2013 - Mac The Fire Truck
Bettie M. Steinberg Has Recently Been Recognized by Strathmore’s Who’s Who Publication
Bettie M. Steinberg, of Manhasset, New York, has recently been recognized by Strathmore’s Who’s Who Registry for her outstanding contributions and achievements in field of Medical Research. About Bettie M. Steinberg Bettie M. Steinberg is Chief Scientific Officer at the Feinstein... - February 06, 2013 - Strathmore Who's Who
Join the Team Contributing DNA Toward a Cure for Tourette Syndrome at Rutgers University
Yale University’s Dr. Robert King will interview individuals and families interested in participating in the genetics sharing program, in conjunction with the New Jersey Center for Tourette Syndrome, on February 14, 15 and 16 at Rutgers. - February 01, 2013 - New Jersey Center for Tourette Syndrome
New Jersey Tourette Syndrome Families Invited to Take Part in Research Conference
Current TS treatments and genetics research will be discussed March 9 at Overlook Medical Center’s Atlantic Neuroscience Institute. - February 01, 2013 - New Jersey Center for Tourette Syndrome
Paid Diabetes Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Age 18+ with Type 2 Diabetes
This trial is a 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naive subjects with T2DM inadequately controlled on a maximum tolerated dose or maximum dose according to local label of GLP-1 receptor agonist and metformin. - January 29, 2013 - Achieve Clinical Research
MOgene Announces Partnership with Intuitive Genomics to Expand Bioinformatics Capabilities
MOgene LC, a full service genomics service provider based in Saint Louis, MO announces a partnership with Intuitive Genomics, Inc. to further expand its bioinformatics capabilities. This decision follows several years of successfully working with Intuitive Genomics to deliver some very promising... - January 28, 2013 - MOgene, LC
IonSense Awarded Massachusetts Workforce Training Grant. Adds New Sales Management.
IonSense, Inc. announced that they are a recipient of one of the 87 Workforce Training Grants awarded by the state of Massachusetts. This grant will enable the company to provide training to a number of employees in the areas of software development and engineering. “We are growing our... - January 25, 2013 - IonSense, Inc.
Stevens Undergraduates Present Research on Reducing Back Pain
Lower back pain is the second most common cause of disability for adults in the United States. Faced with the rising number of individuals suffering from the condition, undergraduate students Emily Noonan and Hanna Sidoti at the Stevens Institute of Technology will be presenting their research on... - January 24, 2013 - Stevens Institute of Technology
TechNavio Announces the Publication of Its Research Report - Global Non-Small Cell Lung Cancer Drugs Market 2012-2016
TechNavio's analysts forecast the Global Non-small Cell Lung Cancer market to grow at a CAGR of 2.77 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Ophthalmic Drugs market has also been witnessing the trend of emergence of personalized medicines. However, the increasing use of complementary and alternative medicine could pose a challenge to the growth of this market. - January 24, 2013 - TechNavio
EEG Awareness Weeks – What EEG Can do for a Trial
The Siesta Group announces the "EEG Awareness Weeks" from Jan 7 to Mar 31, 2013. During this time The Siesta Group’s CEO Georg Dorffner and CSO Peter Anderer will hold free webinars on the topic "What EEG can do for a trial." A free feasibility analysis concerning efforts and costs of including EEG in an early or late phase trial to address CNS efficacy or safety of a drug will be offered to all participants. - January 19, 2013 - The Siesta Group Schlafanalyse GmbH
Thalassemia Gene Therapy Study Begins Treating Participants
The first U.S.-based clinical trial in gene therapy has begun treating trial participants. This important Phase 1 trial introduces a functional version of a beta-globin gene into patients' stem cells. - January 13, 2013 - Cooley's Anemia Foundation
Families of Spinal Muscular Atrophy Committed $2.5 Million to Funding SMA Research in 2012
Families of SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy by funding and advancing a comprehensive research program, which includes: Basic Research to reveal the best ways of making SMA drugs; Drug Discovery to make practical new drugs, and; Clinical Trial resources... - January 01, 2013 - Cure SMA
Families of Spinal Muscular Atrophy Awards $710,000 for Basic Research to Identify New and More Effective Approaches for SMA Therapies
Continued investment in basic research leads to greater understanding of the exact nature, causes, and consequences of SMA. This knowledge is key to ensuring that the most effective SMA treatments can be identified and developed as quickly as possible. - December 29, 2012 - Cure SMA
Families of Spinal Muscular Atrophy Grants New Research Funding of $140,000 to Dr. Didonato of Northwestern University
Families of SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy by funding and advancing a comprehensive research program. This new research funding will support a project at Northwestern University to better understand when and where SMN protein is needed in less severe... - December 28, 2012 - Cure SMA